Tema Oncology ETF
CANC
3 hedge funds and large institutions have $250K invested in Tema Oncology ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.43% more ownership
Funds ownership: 0% → 1.43% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$211K |
| 2 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$7.43K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.53K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $237K | +$211K | +8,997 | New |
|
|
HI
2
Harbour Investments
Madison,
Wisconsin
| $8.34K | +$7.43K | +316 | New |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $3.96K | +$3.53K | +150 | New |
|
CANC Hedge Fund Activity: Q4 2023 in Review
3 of the 6,865 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q4 2023, worth a combined $250K.
Buyers outnumbered sellers: 3 funds opened new CANC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $211K.
- 3 institutional investors held Tema Oncology ETF (CANC) as of Q4 2023, up from 0 in Q3 2023.
- Funds reported $250K of Tema Oncology ETF stock for Q4 2023.
- 3 funds opened new Tema Oncology ETF positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest Tema Oncology ETF buyer in Q4 2023 was Jane Street, an estimated $211K added.
Based on aggregated 13F filings for Q4 2023.